Zhude Tu's profile

Zhude Tu

Principal Investigator

Washington University in St. Louis

I'm working on

8 months ago

Radiopharmaceuticals, PET Imaging, Medicinal Chemistry, Neuroinflammation

About

Zhude Tu advances PET radiotracers from discovery to first-in-human studies. Portfolio spans VAChT and S1P receptor imaging agents, supported by NIH R01s (~$7.7M). Holds an issued S1PR1 imaging patent and a provisional S1PR2 filing.

Partnering listings

Learn more

Washington University in St. Louis

PET radioligands for imaging S1PR5 in CNS disorders

Novel positron emission tomography (PET) radiotracers targeting sphingosine-1-phosphate receptor 5 (S1PR5) for non-invasive investigation of CNS and autoimmune disorders. Leverages highly selective S1PR5 agonist compound...

TechnologyConceptualUniversity

Zhude Tu

Principal Investigator

Washington University in St. Louis

Work experience

Washington University in St. Louis

Principal Investigator

Top industry applications

Not enough data yet.
Results may appear later and can be imperfect.

Open to opportunities in

Not enough data yet.
Results may appear later and can be imperfect.

Last updated Jan 2026